
TruBridge Inc (TBRG) Stock Forecast & Price Target
TruBridge Inc (TBRG) Analyst Ratings
Bulls say
TruBridge Inc. has reported a significant increase in Patient Care gross margins, rising to 59.6% due to effective cost rationalization and unexpected non-recurring revenue, highlighting the firm’s operational efficiency. Additionally, both the Financial Health and Patient Care segments demonstrated organic revenue growth of 5% year-over-year, pointing to strong market performance and successful strategic initiatives, such as the Viewgol acquisition and improved execution across operations. Further, projections for FY25 reflect a revenue increase from $349 million to $353 million, underscoring a positive growth trajectory amid greater client acquisition and market expansion efforts in the healthcare sector.
Bears say
TruBridge Inc. faces significant challenges reflected in a substantial decline in bookings, with a reported 40% year-over-year decrease in Financial Health bookings and over 50% drop in Patient Care bookings, contributing to an overall decline of 45% in total bookings. Moreover, the company's revenue guidance for the first quarter of 2025 is projected to be 1% below consensus expectations, indicating weaker performance relative to market anticipations. Despite management’s optimism regarding potential policy tailwinds and expectations for improved deal closures in the first half of 2025, there are inherent risks and investor apprehension that may negatively impact the stock's outlook.
This aggregate rating is based on analysts' research of TruBridge Inc and is not a guaranteed prediction by Public.com or investment advice.
TruBridge Inc (TBRG) Analyst Forecast & Price Prediction
Start investing in TruBridge Inc (TBRG)
Order type
Buy in
Order amount
Est. shares
0 shares